The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Email: mcarrasco@akebia.com
(C) 2024 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.991 USD | -2.84% |
|
+8.83% | -20.69% |
24/06 | Akebia Therapeutics Names Erik Ostrowski CFO, CBO | MT |
24/06 | Akebia Therapeutics, Inc. Appoints Erik Ostrowski as Senior Vice President and Chief Business Officer | CI |
The options were granted in accordance with Nasdaq Listing Rule 5635(4).
The options have an exercise price of
About
Contact:
Email: mcarrasco@akebia.com
(C) 2024 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-20.69% | 21Cr | |
+15.64% | 12TCr | |
+19.50% | 11TCr | |
+17.47% | 2.6TCr | |
-25.35% | 1.94TCr | |
-19.51% | 1.59TCr | |
-19.43% | 1.51TCr | |
-46.87% | 1.51TCr | |
+62.94% | 1.49TCr | |
+6.27% | 1.39TCr |